Neurofeedback for ADHD: What the Evidence Shows Before You Pay

A change in a brain signal is not the same as a change in daily life. Ask which one you are paying for.

Neurofeedback for ADHD is a substantial choice when a family is already spending time and money on care. Current evidence does not support it as a dependable replacement for established ADHD treatment. Some studies find narrower benefits, but better-controlled trials often find that real and sham training improve symptoms by similar amounts.1234 Before buying a course, ask what exact change you are paying for, how it will be measured, and what happens if it does not occur.

You can take a family’s positive experience seriously while still asking whether the specific brain-feedback method caused the improvement. Those are different questions.

Key takeaways

• In the strongest blinded studies, real and sham neurofeedback improved ADHD symptoms by about the same amount on average.
• Some narrower findings are positive, such as a small benefit for standard protocols and a signal for processing speed.
• Learning to change a brain signal did not reliably mean better symptom control in newer trials.
• “Drug-free” does not mean risk-free. Count time, travel, cost, and the chance of delaying other care.
• Before paying, get a written plan with one daily-life goal, the full price, and a review date.

Zoom

What happens during neurofeedback?

In EEG neurofeedback, sensors on the scalp record electrical activity. A computer turns selected features of that signal into feedback, often through a game or animation. The person practices while the display responds. EEG recording itself does not send electrical current into the brain. In the 2026 personalized-training trial, for example, children tried to move an animated airplane across a screen using feedback from their recorded brain activity.2 Some products sold as neurofeedback add a stimulation signal, so ask whether the device only records.

Methods differ. Some train selected frequency bands, such as a theta-to-beta ratio. Others train slow cortical potentials, which are slower changes in electrical activity. Research has also studied feedback based on blood-flow signals using brain imaging.1 A brand name alone does not tell you which method a clinic offers.

Keep three categories separate. Neurofeedback uses a recorded brain signal. A therapeutic video game can train attention without recording that signal. Electrical nerve stimulation delivers current. (NP FADY covers both in ADHD devices and video games.) Evidence for one category cannot establish that another works.

If a provider says the course will “retrain the brain,” ask them to translate that claim into daily life. Does it mean fewer missed assignments? Less interrupting? A faster score on a computer task? A change in an EEG pattern? These are not interchangeable goals.

What did the large review actually find?

Westwood and colleagues’ review included 38 randomized trials with 2,472 participants ages 5 to 40. Its search ended July 25, 2023. The main symptom analysis used only the trials with ratings from people thought unlikely to know the treatment assignment.1

Excluding adults did not change the main conclusion. Longer follow-up did not establish a symptom benefit; processing speed again showed a signal. These findings support further targeted research, not a promise of broad or lasting ADHD relief.1

A standardized difference places results from different scales on a common scale. Zero means no average difference. A confidence interval describes uncertainty around the estimate. Here, the main result was close to zero. The smaller positive findings deserve attention, but they do not answer whether a particular child will finish homework with less help.

Why a sham comparison matters

A sham group receives a convincing version of the treatment experience without the intended feedback relationship. This helps separate the tested method from other parts of the package: appointments, practice, encouragement, structure, and hope.

The large two-site U.S. trial known as ICAN (International Collaborative ADHD Neurofeedback) used a blinded sham comparison. Its long follow-up found that both groups improved a lot. It did not show a lasting extra benefit from the brain-wave training itself. At 25 months, 120 of the 142 participants in the follow-up report were assessed.3 That is follow-up of the same trial, not another independent experiment.

This does not mean children pretended to improve. It means improvement alone cannot tell us which ingredient helped. A child might gain from a regular, supportive practice routine. A family might also begin school supports during the same months. Symptoms can change over time, and families often start a new service during a particularly hard period.

Consider a hypothetical example. A child starts neurofeedback and a new homework check-in in the same month. Missing work falls from six assignments to two. That change matters. It does not identify which part of the plan caused it. A testimonial can describe the change honestly without proving the treatment’s specific effect.

Blinding is also imperfect. A teacher may not know the assigned treatment but may notice that a child attends sessions. A parent may guess the assignment. The useful question is how a study reduced these problems and checked whether masking held up.

What has appeared since the review’s cutoff?

The 38-trial review is an important starting point, not the entire evidence available in September 2026.

Personalized upper-alpha training, 2026. Wang and colleagues studied children ages 6 to 12. The published abstract reports 48 randomized children (the trial registry lists 51 enrolled), with fewer assessed at the six-month follow-up. Across eight sessions, more children receiving real feedback learned to change the trained brain signal (about 81% versus 36% with sham), with some specific motor-speed and reaction-time findings. Parent-rated ADHD symptoms did not improve more than with sham, either after treatment or at follow-up.2 Learning to change a recorded signal therefore did not establish better symptom control.

Mobile neurofeedback, 2025. A blinded Korean study randomized 188 children across ADHD and neurotypical groups; 139 were analyzed. Those counts come from the paper’s results and tables; its abstract gives 139 and 120. It found changes in brain signals, especially when training was added to medicine. But real training did not clearly beat sham on ADHD symptoms or thinking tests.4 The entire sample should not be described as children with ADHD.

Combined treatment, 2025. Another trial involved 60 children and teens, ages 8 to 18, receiving both respiratory biofeedback and neurofeedback. The randomized contrast was active versus sham median-nerve stimulation. Because both groups received neurofeedback, the study cannot isolate its benefit.5

A newer review with a different question. Zhong and colleagues’ 2025 review reported benefits for some thinking skills. It searched through January 2024 and focused on executive function, with varied comparison groups and limited assessor blinding.6 It does not overturn the blinded core-symptom findings by answering a different question.

The practical conclusion remains cautious. A stronger EEG signal, a quicker response on a task, and fewer ADHD problems at home are separate outcomes. A provider should be able to name which one supports the service being proposed.

What remains uncertain?

Families often ask whether an average result could hide a group that benefits more. It could. That possibility needs a reliable way to identify the group before treatment, followed by testing in new patients. It is not enough to look backward and describe the people who improved.

Ask what “personalized” means. Does the provider adjust a setting from session to session? Choose among several protocols? Use a validated test that predicts a better outcome? Customizing a service does not by itself prove that the customization improves results.

Age matters too. Evidence from school-age children does not automatically establish benefit for an adult with workplace problems. Nor should a positive result in adults be treated as proof for a young child. Ask for evidence that matches the person’s age, diagnosis, current treatment, and main difficulty.

Long-term claims require equal care. A score that remains better than before treatment is not the same as a lasting advantage over a comparison group. Ask whether follow-up retained most participants, tracked other care, and compared the original groups.

Harms include burden and delayed care

“Drug-free” does not mean risk-free. The absence of a major safety signal in one study cannot establish safety for every protocol, device, or person. Adverse-event reporting is uneven, and some studies are too small to detect uncommon problems. The ICAN study reported similar adverse-event patterns in its active and control groups.7

Ask how the clinic records discomfort, headaches, fatigue, sleep changes, mood changes, and reasons for stopping. These are questions to monitor, not a claim that neurofeedback causes each problem. New or worsening symptoms deserve discussion with the treating clinician.

Time is part of the cost. Count setup, travel, missed work, childcare, sessions, and follow-up. A course that fits poorly can create conflict even if a child likes the game. Ask the child what the experience is like without making them responsible for justifying the expense.

There is also the cost of waiting. If the child is falling behind or family conflict is growing, spending months on an uncertain approach may delay care directed at those problems. For children and teens, U.S. pediatric guidance supports age-appropriate medication, parent training, classroom interventions, and educational supports as parts of ADHD care.8

You do not need to choose between “try everything” and “give up.” You can decide which unmet need deserves the next limited hour or dollar.

A buyer’s checklist for a proposed package

This is a practical decision tool, not a tested treatment protocol. Ask for written answers before paying a large nonrefundable amount.

A certificate and a health-professional license answer different questions. A certificate may show training in a method. A license identifies a regulated professional role. Neither alone establishes that the proposed course is effective for your child’s goal. Verify claims with the issuing organization or licensing board.

Watch how the provider handles a fair question. Can they discuss a negative trial without saying the participants simply failed to try? Can they explain the difference between learning the EEG task and getting better at school? A clear, bounded answer is more useful than a dramatic brain image.

Put the actual cost on one page

There is no single verified national price that applies to every protocol and package. Use your written quote instead of an online “typical cost.”

• Initial assessment: $____
• Sessions: ____ sessions × $____ = $____
• Equipment, software, or supplies: $____
• Required reassessment and follow-up: $____
• Travel, childcare, or missed work: $____
• Total expected out-of-pocket cost: $____
• Amount due before the first progress review: $____

Check coverage directly with the insurer using the provider, service, and billing details. A clinic’s statement that it accepts insurance does not establish coverage for your plan or this service. Ask who pays if a claim is denied.

Include the competing choice. What else could the same time or money support? That might be a clinical follow-up, a school meeting, parent training, or help with a specific learning problem. This is not a test of how much you care. It is a way to protect a family budget while matching care to need.

Agree on a review point before starting

If the family and clinician decide to try neurofeedback, keep the plan concrete. Choose a daily-life outcome that matters and can be observed without turning the home into a testing center.

For example: “On school nights, homework starts within 15 minutes of the agreed time with no more than one reminder.” Record a few usual evenings before treatment. At the agreed review, compare similar evenings and note holidays, illness, medication changes, or new school supports.

Pair this with a symptom measure chosen by the clinician. When possible, obtain observations from someone outside the training setting. A parent and teacher may see different things; that difference can guide the discussion rather than becoming a contest over who is right.

Write the review date into the agreement. Ask what result would justify continuing, what would lead to changing the plan, and what would make stopping reasonable. Do not accept an open-ended promise that improvement is always a few more sessions away.

Keep prescribed treatment changes with the clinician. Do not stop medication to make a package more attractive or to conduct your own experiment. School supports should not depend on finishing a private treatment course.

If the main need is daily behavior, read NP FADY’s guide to behavioral parent training. For teens and adults seeking practical skills, see ADHD-focused CBT. For help reviewing diagnosis and the broader plan, see the ADHD care information.

Your next step can be small: bring the written neurofeedback proposal and one daily-life goal to the clinician who knows the ADHD treatment plan. Ask, “Given this evidence, is this the best next use of our time and money?”

Frequently asked questions

What if a provider offers a success guarantee?

Read what counts as success and what the guarantee returns. A refund policy is a contract term; it does not establish clinical effectiveness. Ask for the terms before paying.

What should I bring from a previous course?

Bring the dates, protocol if known, session count, progress records, side effects, and other care used during the same period. These details can help a new clinician interpret what changed.

Related reading on NP FADY

• ADHD Devices and Video Games: What FDA Authorization Means
• Change the Pattern, Not the Child: A Parent’s Guide to Behavioral Training for ADHD
• ADHD Medications Compared: Stimulants vs. Non-Stimulants for Kids and Adults

References

1. Westwood SJ, Aggensteiner PM, Kaiser A, et al. Neurofeedback for Attention-Deficit/Hyperactivity Disorder: A Systematic Review and Meta-Analysis. JAMA Psychiatry. 2025;82(2):118–129. DOI: 10.1001/jamapsychiatry.2024.3702. PMID: 39661381. Full report and supplements.

2. Wang Y, Hui KY, Lu SF, et al. A double-blind randomized controlled trial of personalized upper-alpha neurofeedback in children with ADHD. Journal of Child Psychology and Psychiatry. Published online June 21, 2026. DOI: 10.1111/jcpp.70188. PMID: 42324882.

3. Neurofeedback Collaborative Group. Neurofeedback for Attention-Deficit/Hyperactivity Disorder: 25-Month Follow-up of Double-Blind Randomized Controlled Trial. Journal of the American Academy of Child & Adolescent Psychiatry. 2023;62(4):435–446. PMID 36521694. DOI: 10.1016/j.jaac.2022.07.862. Full text.

4. Kim JW, Kim BN, Kim JI, Yang CM, Kwon J. Effects of Mobile Neurofeedback on Theta-Gamma Coupling and Clinical Outcomes in Children with ADHD: A Double-Blind, Sham-Controlled Randomized Clinical Trial. Neuropsychiatric Disease and Treatment. 2025;21:2733–2746. PMID 41368620. DOI: 10.2147/NDT.S554756. Full text.

5. Santamaría-Vázquez E, Estudillo-Guerra A, Ali L, Martinez D, Hornero R, Morales-Quezada L. Effects of a novel non-pharmacological intervention based on respiratory biofeedback, neurofeedback and median nerve stimulation to treat children with ADHD. Frontiers in Human Neuroscience. 2025;19:1478501. DOI: 10.3389/fnhum.2025.1478501. PMID: 39989722.

6. Zhong X, Yuan X, Dai Y, Zhang X, Jiang C. Neurofeedback training for executive function in ADHD children: a systematic review and meta-analysis. Scientific Reports. 2025;15(1):28148. DOI: 10.1038/s41598-025-94242-4. PMID: 40750997. Publisher PDF.

7. Neurofeedback Collaborative Group. Double-Blind Placebo-Controlled Randomized Clinical Trial of Neurofeedback for Attention-Deficit/Hyperactivity Disorder With 13-Month Follow-up. Journal of the American Academy of Child & Adolescent Psychiatry. 2021;60(7):841–855. DOI: 10.1016/j.jaac.2020.07.906. PMID: 32853703.

8. Wolraich ML, Hagan JF Jr, Allan C, et al. Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents. Pediatrics. 2019;144(4):e20192528. PMID 31570648. DOI: 10.1542/peds.2019-2528. Full text.

This article is for education and is not a substitute for diagnosis or treatment from a qualified health professional. Do not start, stop, or change medication without your prescriber’s guidance. Evidence last checked September 28, 2026.

If you or someone you know is in crisis

• Call 911 or go to your nearest emergency room for any life-threatening emergency.
• 988 Suicide & Crisis Lifeline — call or text 988, or chat at 988lifeline.org, available 24/7, free and confidential. En español: marque 988 y oprima 2, o envíe AYUDA al 988. Deaf or hard of hearing: 988 videophone (ASL) or TTY 711 then 988. Veterans: 988 and press 1, or text 838255.
• Crisis Text Line — text HOME to 741741.
• The Trevor Project (crisis support for LGBTQ+ young people) — call 1-866-488-7386, or text START to 678-678.
• National Sexual Assault Hotline (RAINN) — call 1-800-656-HOPE (4673) or text HOPE to 64673; free, confidential, 24/7. Online chat at RAINN.org/hotline.
• National Domestic Violence Hotline — call 1-800-799-SAFE (7233) or text START to 88788; 24/7, help in 200+ languages. Online chat at TheHotline.org. If your phone or computer may be monitored, calling from a safer device is an option.
• Riverside County — Inland SoCal Crisis Helpline 951-686-HELP (4357), 24/7 (Inland SoCal United Way / 211+, in partnership with RUHS-BH); Community Access, Referral, Evaluation and Support (CARES) Line 800-499-3008, 24/7.
• San Bernardino County — Access Unit (Behavioral Health Helpline) 888-743-1478, 24/7; Mobile Crisis/CCRT 800-398-0018 (24/7, all ages) or text 909-420-0560. Arrowhead Regional Medical Center (ARMC) has a dedicated walk-in adolescent psychiatric ER (ages 13–17).
• Children under 13 — call 911 for immediate danger, contact your county's mobile crisis team (they respond to all ages), or go to the nearest pediatric emergency room.
• California Peer-Run Warm Line (non-crisis — someone to talk to) — call or text 1-855-600-WARM (9276); daytime and evening hours, not a 24/7 line.
• NP Fady (non-emergency) — for routine scheduling or questions, call (909) 707-6261. This line is not monitored for emergencies.